233 related articles for article (PubMed ID: 31319144)
1. Pulmonary delivery of Nanocomposite Microparticles (NCMPs) incorporating miR-146a for treatment of COPD.
Mohamed A; Pekoz AY; Ross K; Hutcheon GA; Saleem IY
Int J Pharm; 2019 Oct; 569():118524. PubMed ID: 31319144
[TBL] [Abstract][Full Text] [Related]
2. Bovine serum albumin adsorbed PGA-co-PDL nanocarriers for vaccine delivery via dry powder inhalation.
Kunda NK; Alfagih IM; Dennison SR; Tawfeek HM; Somavarapu S; Hutcheon GA; Saleem IY
Pharm Res; 2015 Apr; 32(4):1341-53. PubMed ID: 25297713
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary Delivery of Proteins Using Nanocomposite Microcarriers.
Alfagih I; Kunda N; Alanazi F; Dennison SR; Somavarapu S; Hutcheon GA; Saleem IY
J Pharm Sci; 2015 Dec; 104(12):4386-4398. PubMed ID: 26505151
[TBL] [Abstract][Full Text] [Related]
4. Polymeric nanoparticles for the delivery of miRNA to treat Chronic Obstructive Pulmonary Disease (COPD).
Mohamed A; Kunda NK; Ross K; Hutcheon GA; Saleem IY
Eur J Pharm Biopharm; 2019 Mar; 136():1-8. PubMed ID: 30615927
[TBL] [Abstract][Full Text] [Related]
5. Dry powder pulmonary delivery of cationic PGA-co-PDL nanoparticles with surface adsorbed model protein.
Kunda NK; Alfagih IM; Dennison SR; Somavarapu S; Merchant Z; Hutcheon GA; Saleem IY
Int J Pharm; 2015 Aug; 492(1-2):213-22. PubMed ID: 26169146
[TBL] [Abstract][Full Text] [Related]
6. Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers.
Li X; Vogt FG; Hayes D; Mansour HM
J Pharm Sci; 2014 Sep; 103(9):2937-2949. PubMed ID: 24740732
[TBL] [Abstract][Full Text] [Related]
7. Budesonide dry powder for inhalation: effects of leucine and mannitol on the efficiency of delivery.
Rattanupatam T; Srichana T
Drug Deliv; 2014 Sep; 21(6):397-405. PubMed ID: 24401124
[TBL] [Abstract][Full Text] [Related]
8. Rifampicin-Carbohydrate Spray-Dried Nanocomposite: A Futuristic Multiparticulate Platform For Pulmonary Delivery.
Mehanna MM; Mohyeldin SM; Elgindy NA
Int J Nanomedicine; 2019; 14():9089-9112. PubMed ID: 31819421
[TBL] [Abstract][Full Text] [Related]
9. Poly(glycerol adipate-co-ω-pentadecalactone) spray-dried microparticles as sustained release carriers for pulmonary delivery.
Tawfeek H; Khidr S; Samy E; Ahmed S; Murphy M; Mohammed A; Shabir A; Hutcheon G; Saleem I
Pharm Res; 2011 Sep; 28(9):2086-97. PubMed ID: 21533998
[TBL] [Abstract][Full Text] [Related]
10. Development of drug alone and carrier-based GLP-1 dry powder inhaler formulations.
Babenko M; Alany RG; Calabrese G; Kaialy W; ElShaer A
Int J Pharm; 2022 Apr; 617():121601. PubMed ID: 35181460
[TBL] [Abstract][Full Text] [Related]
11. Preparation and in vivo absorption evaluation of spray dried powders containing salmon calcitonin loaded chitosan nanoparticles for pulmonary delivery.
Sinsuebpol C; Chatchawalsaisin J; Kulvanich P
Drug Des Devel Ther; 2013; 7():861-73. PubMed ID: 24039397
[TBL] [Abstract][Full Text] [Related]
12. Development of Inhalable Nanostructured Lipid Carriers for Ciprofloxacin for Noncystic Fibrosis Bronchiectasis Treatment.
Almurshedi AS; Aljunaidel HA; Alquadeib B; Aldosari BN; Alfagih IM; Almarshidy SS; Eltahir EKD; Mohamoud AZ
Int J Nanomedicine; 2021; 16():2405-2417. PubMed ID: 33814907
[TBL] [Abstract][Full Text] [Related]
13. Influence of excipients on physical and aerosolization stability of spray dried high-dose powder formulations for inhalation.
Shetty N; Park H; Zemlyanov D; Mangal S; Bhujbal S; Zhou QT
Int J Pharm; 2018 Jun; 544(1):222-234. PubMed ID: 29678544
[TBL] [Abstract][Full Text] [Related]
14. Formulation and characterization of inhalable magnetic nanocomposite microparticles (MnMs) for targeted pulmonary delivery via spray drying.
Stocke NA; Meenach SA; Arnold SM; Mansour HM; Hilt JZ
Int J Pharm; 2015 Feb; 479(2):320-8. PubMed ID: 25542988
[TBL] [Abstract][Full Text] [Related]
15. In Vitro Characterization of Inhalable Cationic Hybrid Nanoparticles as Potential Vaccine Carriers.
Alfagih IM; Kaneko K; Kunda NK; Alanazi F; Dennison SR; Tawfeek HM; Saleem IY
Pharmaceuticals (Basel); 2021 Feb; 14(2):. PubMed ID: 33670611
[TBL] [Abstract][Full Text] [Related]
16. Spray-freeze-drying production of thermally sensitive polymeric nanoparticle aggregates for inhaled drug delivery: effect of freeze-drying adjuvants.
Cheow WS; Ng ML; Kho K; Hadinoto K
Int J Pharm; 2011 Feb; 404(1-2):289-300. PubMed ID: 21093560
[TBL] [Abstract][Full Text] [Related]
17. Optimization of Acetalated Dextran-Based Nanocomposite Microparticles for Deep Lung Delivery of Therapeutics via Spray-Drying.
Wang Z; Meenach SA
J Pharm Sci; 2017 Dec; 106(12):3539-3547. PubMed ID: 28827039
[TBL] [Abstract][Full Text] [Related]
18. Leucine improves the aerosol performance of dry powder inhaler formulations of siRNA-loaded nanoparticles.
Xu Y; Harinck L; Lokras AG; Gerde P; Selg E; Sjöberg CO; Franzyk H; Thakur A; Foged C
Int J Pharm; 2022 Jun; 621():121758. PubMed ID: 35483619
[TBL] [Abstract][Full Text] [Related]
19. Characterization of spray dried powders with nucleic acid-containing PEI nanoparticles.
Keil TWM; Feldmann DP; Costabile G; Zhong Q; da Rocha S; Merkel OM
Eur J Pharm Biopharm; 2019 Oct; 143():61-69. PubMed ID: 31445157
[TBL] [Abstract][Full Text] [Related]
20. Preparation and Characterization of Doripenem-Loaded Microparticles for Pulmonary Delivery.
Yildiz-Peköz A; Akbal O; Tekarslan SH; Sagirli AO; Mulazimoglu L; Morina D; Cevher E
J Aerosol Med Pulm Drug Deliv; 2018 Dec; 31(6):347-357. PubMed ID: 29877747
[No Abstract] [Full Text] [Related]
[Next] [New Search]
